Artificial Intelligence (AI) in Construction - Thematic Intelligence
Summary
The construction industry has been slower than other sectors in implementing AI as it is one of the least digitized industries. However, AI adoption in the construction industry is gaining traction and will continue to grow over the coming years. AI has the potential to transform processes across the project lifecycle. According to GlobalData forecasts, the total AI market will be worth $908.7 billion in 2030, having grown at a compound annual growth rate (CAGR) of 35.2% from $81.3 billion in 2022.
The industry is at a disadvantage when considering AI adoption as it is a difficult industry to digitalize. The vast and complex data sets needed for Building Information Management (BIM) have been historically difficult to process. However, due to developments in chips and cloud computing this is becoming possible. The construction industry’s tight profit margins, critical deadlines, and health and safety issues, also mean the already under digitalized sector has been hesitant to invest in new technology. However, the construction sector could reap benefits from efficiencies gained using AI. AI applications in the construction industry can facilitate planning, design, modelling, safety, site monitoring and maintenance, and emission tracking.
The construction industry is widely considered one of the least digitized industries and has been slower to adopt AI than other sectors. This is due to a number of unique challenges the industry faces. Historically, computers did not have the processing power necessary to crunch the data needed for BIM, as it is often vast and unstructured. Access to this data was also notably inconvenient. However, in 2023, due to developments in computer power, semiconductors, and cloud computing, which facilitates data sharing, AI implementation has grown considerably.
Scope
This report provides an overview of the AI theme. The detailed value chain comprises of four segments: human AI interaction, decision making AI, motion and creation. Leading and challenging vendors are identified across both segments.
It identifies construction challenges, such as ESG, labor shortages, and safety, and an impact assessment of AI on the construction industry, addressing these challenges.
It includes three case studies, outlining market-leading use cases of AI in construction to solve specific challenges such as operational technology vulnerabilities and secure procurement processes.
It contains comprehensive industry analysis, including forecasts for AI revenues to 2030, and insight from GlobalData’s Job Analytics and Social Media Analytics databases. It contains details of M&A deals driven by the AI theme, and a timeline highlighting AI milestones and events in construction.
The report has extensive coverage and analysis of relevant companies’ positions in the AI theme. This includes leading adopters, vendors, and specialist AI vendors in construction.
It includes GlobalData’s unique thematic scorecard that ranks construction companies according to their positioning in the ten themes most important to the industry, of which metaverse is one.
Reasons to Buy
This report will help you to understand AI and its potential impact on the construction sector.
Benchmark your company against your competitors, by comparing how prepared 46 companies in the construction sector are for AI disruption.
Identify and differentiate between the leading AI vendors and formulate an adoption plan for your company.
Position yourself for future success by investing in the right AI technologies. Cut through the noise with GlobalData’s priority ratings for each AI technology for each segment of the industry (conceptual design, feasibility studies, planning and permitting, financing, design and engineering, construction, and operations and maintenance).
Develop relevant and credible sales and marketing messages for construction companies by understanding key industry challenges and where AI use cases are most useful.
Identify attractive investment targets by understanding which companies are most advanced in the themes that will determine future success in the construction industry.
Burning Rock Biotech Ltd Company Overview
Burning Rock Biotech Ltd Company Snapshot
Burning Rock Biotech Ltd Pipeline Products and Ongoing Clinical Trials Overview
Burning Rock Biotech Ltd – Pipeline Analysis Overview
Burning Rock Biotech Ltd - Key Facts
Burning Rock Biotech Ltd - Major Products and Services
Burning Rock Biotech Ltd Pipeline Products by Development Stage
Burning Rock Biotech Ltd Ongoing Clinical Trials by Trial Status
Burning Rock Biotech Ltd Pipeline Products Overview
CDx Assay - ABSK091
CDx Assay - ABSK091 Product Overview
Companion Diagnostic Assay - Prostate Cancer
Companion Diagnostic Assay - Prostate Cancer Product Overview
OncoCompass Target CDx Test - Tepotinib
OncoCompass Target CDx Test - Tepotinib Product Overview
OverC Multi-Cancer Detection Blood Test Kit
OverC Multi-Cancer Detection Blood Test Kit Product Overview
OverC Multi-Cancer Detection Blood Test Kit Clinical Trial
Burning Rock Biotech Ltd - Key Competitors
Burning Rock Biotech Ltd - Key Employees
Burning Rock Biotech Ltd - Locations And Subsidiaries
Head Office
Recent Developments
Burning Rock Biotech Ltd, Recent Developments
Jun 28, 2023: Burning Rock Announces Resignation and Appointment of Directors
Apr 27, 2023: Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023
Mar 28, 2023: Burning Rock Biotech Reports Fourth Quarter and Full Year 2022 Financial Results
Nov 15, 2022: Burning Rock Reports Third Quarter 2022 Financial Results
Sep 08, 2022: Burning Rock Announces Results of 2022 Annual General Meeting
Aug 03, 2022: Burning Rock Announces 2022 Annual General Meeting to be Held on September 8, 2022
Jul 14, 2022: Burning Rock Announces Resignation of Director
Jun 24, 2022: Burning Rock Announces Changes to Board Composition
May 31, 2022: Burning Rock Reports First Quarter 2022 Financial Results
Mar 21, 2022: Burning Rock Reports Fourth Quarter and Full Year 2021 Financial Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Burning Rock Biotech Ltd Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Burning Rock Biotech Ltd Pipeline Products by Equipment Type
Table 3: Burning Rock Biotech Ltd Pipeline Products by Indication
Table 4: Burning Rock Biotech Ltd, Key Facts
Table 5: Burning Rock Biotech Ltd, Major Products and Services
Table 6: Burning Rock Biotech Ltd Number of Pipeline Products by Development Stage
Table 7: Burning Rock Biotech Ltd Pipeline Products Summary by Development Stage
Table 8: Burning Rock Biotech Ltd Ongoing Clinical Trials by Trial Status
Table 9: Burning Rock Biotech Ltd Ongoing Clinical Trials Summary
Table 18: OverC Multi-Cancer Detection Blood Test Kit - A Prospective Multi-cancer Early-detection and Interventional Study in Asymptomatic Individuals: PREVENT
Table 19: OverC Multi-Cancer Detection Blood Test Kit - A Prospective, Multicenter Study on Development and Validation of the Performance of a cfDNA Methylation-based Model for Early Cancer Detection (Pan-cancer Early Detection project, PREDICT Study)
Table 20: OverC Multi-Cancer Detection Blood Test Kit - Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Myeloma: a Proof of Concept Study
Table 21: OverC Multi-Cancer Detection Blood Test Kit - Assessment of Early Detection Based on Liquid Biopsy in Intracranial Tumors: a Prospective Observational Study
Table 22: OverC Multi-Cancer Detection Blood Test Kit - Burning Rock Pan-cancer Early Detection Project (PREDICT): A Prospective, Multicenter Study to Develop and Validate the Performance of a Cfdna Methylation Based Model on Early Cancer Detection
Table 23: OverC Multi-Cancer Detection Blood Test Kit - Pan-cancer Early-stage Detection by Liquid Biopsy in Peripheral Blood: A Multi-center, Prospective Observational Study
Table 24: Burning Rock Biotech Ltd, Key Employees
Table 25: Glossary
List of Figures
Figure 1: Burning Rock Biotech Ltd Pipeline Products by Equipment Type
Figure 2: Burning Rock Biotech Ltd Pipeline Products by Development Stage
Figure 3: Burning Rock Biotech Ltd Ongoing Clinical Trials by Trial Status